Dual-Functional Liposomes with Carbonic Anhydrase IX Antibody and BR2 Peptide Modification Effectively Improve Intracellular Delivery of Cantharidin to Treat Orthotopic Hepatocellular Carcinoma Mice
Liposomal nanotechnology has a great potential to overcome the current major problems of chemotherapy. However, the lack of penetrability and targetability retards the successful delivery of liposomal carriers. Previously, we showed that BR2 peptide modification endowed cantharidin-loaded liposomes...
Main Authors: | Xue Zhang, Congcong Lin, Waikei Chan, Kanglun Liu, Aiping Lu, Ge Lin, Rong Hu, Hongcan Shi, Hongqi Zhang, Zhijun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/18/3332 |
Similar Items
-
Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma
by: An-Ping Xiang, et al.
Published: (2022-08-01) -
Carbonic Anhydrase IX and Survivin in Colorectal Adenocarcinoma Cells: Slovakian Population Study
by: Zuzana Kováčová, et al.
Published: (2021-09-01) -
Targeting Carbonic Anhydrase IX Activity and Expression
by: Brian P. Mahon, et al.
Published: (2015-01-01) -
Carbonic Anhydrase IX—Mouse versus Human
by: Martina Takacova, et al.
Published: (2019-12-01) -
An update on anticancer drug development and delivery targeting carbonic anhydrase IX
by: Justina Kazokaitė, et al.
Published: (2017-11-01)